IGY Polyclonal Antibodies Market

Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.

IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.

IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.

The scientific community has long known that IgY has the proven ability to modulate immune systems. The G.I. tract is the typical entry point for foreign pathogens. By removing pathogens IgY can alleviate stress on the overall system thereby optimizing the body?s natural defense systems. When consumed orally or topically, IgY can identify and attack foreign pathogens that enter via the gut. Antibodies work on both viral and bacterial infections possibly reducing the need for antibiotics.

IgY antibodies have been studied extensively by many government, university and private industry research groups over the years, all concluding the efficacy of IgY in improving overall health. IgY has been used safely in nutraceuticals and vitamins for many years.

IGY Polyclonal Antibodies Market contains market size and forecasts of IGY Polyclonal Antibodies in Global, including the following market information:

Global IGY Polyclonal Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global IGY Polyclonal Antibodies market was valued at 7 million in 2021 and is projected to reach US$ 15 million by 2028, at a CAGR of 10.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Primary Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of IGY Polyclonal Antibodies include Merck, IGY Life Sciences, Abcam, Genway Biotech, Good Biotech, Gallus Immunotech, Creative Diagnostics, Agrisera and Innovagen AB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IGY Polyclonal Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global IGY Polyclonal Antibodies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global IGY Polyclonal Antibodies Market Segment Percentages, by Type, 2021 (%)

Primary Antibody

Secondary Antibody

Global IGY Polyclonal Antibodies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global IGY Polyclonal Antibodies Market Segment Percentages, by Application, 2021 (%)

Academic Research

Commercial

Global IGY Polyclonal Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global IGY Polyclonal Antibodies Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies IGY Polyclonal Antibodies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies IGY Polyclonal Antibodies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Merck

IGY Life Sciences

Abcam

Genway Biotech

Good Biotech

Gallus Immunotech

Creative Diagnostics

Agrisera

Innovagen AB

Capra Science

YO Proteins

GeneTex